Target intelligence / Profile preview

Ribosomal protein L35a pseudogene 21 (RPL35AP21)

Target: RPL35AP21
Molecular classification: Other, Pseudogene

Overview

Ribosomal protein L35a pseudogene 21 (RPL35AP21) is a processed pseudogene in humans derived from the ribosomal protein L35a (RPL35A) gene. Unlike its parent gene, RPL35AP21 does not encode a functional protein and is not known to have biological function or involvement in disease. There are multiple RPL35A pseudogenes dispersed throughout the human genome, but only the functional RPL35A gene encodes a ribosomal protein, a component of the large 60S ribosomal subunit responsible for protein synthesis. RPL35AP21 has no direct relevance as a therapeutic target, biomarker, or drug-interacting protein[1][2][6].

Other names: RPL35A_11_983

Beyond the preview

Go deeper on Ribosomal protein L35a pseudogene 21 (RPL35AP21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L35a pseudogene 21 (RPL35AP21).

Explore the full profile